you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Jan 18, 16:00
5052.80 -154.80 (-2.97%)
Volume
AVERAGE VOLUME
5-Day
25,841
10-Day
27,506
30-Day
38,038
21,364
  • Prev. Close

    5207.60

  • Open Price

    5212.00

  • Bid Price (Qty.)

    5042.05 (1)

  • Offer Price (Qty.)

    5052.80 (8)

NSE Live

Jan 18, 16:03
5052.10 -160.70 (-3.08%)
Volume
AVERAGE VOLUME
5-Day
668,098
10-Day
721,967
30-Day
1,043,566
882,411
  • Prev. Close

    5212.80

  • Open Price

    5231.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    5052.10 (30)

Financials

2020 2019 2018 2017 2016
Yearly Results of Dr Reddys Laboratories (in Rs. Cr.) Mar '20 Mar '19 Mar '18 Mar '17 Mar '16  
Net Sales/Income from operations 11,803.00 10,466.70 9,302.60 9,628.10 10,234.80  
Other Operating Income 47.40 158.80 56.70 91.70 57.10  
Total Income From Operations 11,850.40 10,625.50 9,359.30 9,719.80 10,291.90  
EXPENDITURE  
Consumption of Raw Materials 2,556.50 2,103.20 2,011.00 1,817.60 2,072.70  
Purchase of Traded Goods 1,117.20 868.60 671.60 671.50 610.40  
Increase/Decrease in Stocks -99.90 66.00 -51.60 1.90 -28.80  
Power & Fuel -- -- -- -- --  
Employees Cost 2,030.20 1,931.90 1,843.00 1,803.30 1,693.40  
Depreciation 789.20 780.60 774.10 735.10 927.50  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- 998.50 649.50  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 3,376.80 3,356.10 3,555.40 2,681.40 2,951.40  
P/L Before Other Inc. , Int., Excpt. Items & Tax 2,080.40 1,519.10 555.80 1,010.50 1,415.80  
Other Income 743.20 238.40 204.00 591.20 324.90  
P/L Before Int., Excpt. Items & Tax 2,823.60 1,757.50 759.80 1,601.70 1,740.70  
Interest 47.80 56.80 62.80 57.20 64.10  
P/L Before Exceptional Items & Tax 2,775.80 1,700.70 697.00 1,544.50 1,676.60  
Exceptional Items -- -- -- -- --  
P/L Before Tax 2,775.80 1,700.70 697.00 1,544.50 1,676.60  
Tax -161.90 423.40 130.10 160.40 302.30  
P/L After Tax from Ordinary Activities 2,937.70 1,277.30 566.90 1,384.10 1,374.30  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 2,937.70 1,277.30 566.90 1,384.10 1,374.30  
Equity Share Capital 83.10 83.00 83.00 82.90 85.30  
Reserves Excluding Revaluation Reserves 15,108.80 12,601.10 11,724.80 11,517.70 11,520.10  
Equity Dividend Rate (%) 500.00 400.00 400.00 400.00 400.00  
EPS Before Extra Ordinary  
Basic EPS 177.23 76.98 34.19 83.05 80.59  
Diluted EPS 176.88 76.85 34.12 82.88 80.34  
EPS After Extra Ordinary  
Basic EPS. 177.23 76.98 34.19 83.05 80.59  
Diluted EPS. 176.88 76.85 34.12 82.88 80.34  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs